http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=491513 A Randomised, Open-Label, Proof-of-Concept, Phase II Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer 1 on-line 131072 Terminated GB UNITED KINGDOM II 2025-03-14 00:00:00.0 IMMODULON THERAPEUTICS LTD. Eta Sponsor of orphan designation Rcl Sponsor of clinical trial Net Sponsor of multinational clinical trial 1333 Familial pancreatic carcinoma 424053 Mucinous cystadenocarcinoma of the pancreas 424058 Intraductal papillary mucinous carcinoma of pancreas 424065 Pancreatic solid pseudopapillary neoplasm 424073 Serous cystadenocarcinoma of pancreas 424080 Undifferentiated carcinoma with osteoclast-like giant cells of pancreas Rcl http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=273028 A Randomised, Open-Label, Proof-of-Concept, Phase II Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer - ES 1 Clinical trial 2 Drug clinical trial 1 on-line 4 multicentric 131072 Terminated https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022757-42/ES http://clinicaltrials.gov/ct2/show/NCT01303172 SPAIN